Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China-Reference-Cited by-同舟云学术

Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China

Published:2018-12-14 Issue:8 Volume:1 Page:e185446
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Lu Yuan¹²,Zhang Haibo³⁴,Wang Yongfei¹²,Zhou Tianna¹,Welsh John¹,Liu Jiamin³⁴,Guan Wenchi³⁴,Li Jing³⁴,Li Xi³⁴,Zheng Xin³⁴,Spertus John A.⁵,Masoudi Frederick A.⁶,Krumholz Harlan M.¹²⁷,Jiang Lixin³⁴

Affiliation:

1. Center for Outcomes Research and Evaluation, Yale University/Yale-New Haven Hospital, New Haven, Connecticut

2. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

3. National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China

4. NHC Key Laboratory of Clinical Research for Cardiovascular Medications, Beijing, People’s Republic of China

5. Health Outcomes Research, Saint Luke’s Mid America Heart Institute/University of Missouri-Kansas City, Kansas City

6. Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora

7. Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference34 articles.

1. Optimal medical therapy with or without PCI for stable coronary disease.;Boden;N Engl J Med,2007

2. Effect of PCI on long-term survival in patients with stable ischemic heart disease.;Sedlis;N Engl J Med,2015

3. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.;Fihn;J Am Coll Cardiol,2012

4. Evolution and future perspectives for cardiovascular interventions in China.;Gao;EuroIntervention,2012

5. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention.;Desai;JAMA,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcutaneous Electrical Acupuncture Point Stimulation Is Cardioprotective for Patients With Stable Ischemic Heart Disease;The American Journal of Cardiology;2023-11

2. Quality of Life in Patients Undergoing Percutaneous Coronary Intervention;Clinics and Practice;2023-05-17

3. In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project;Thrombosis Research;2022-08

4. Role of palliative percutaneous coronary intervention in severely symptomatic complex coronary artery disease patients who could not undergo coronary artery bypass surgery;Heart India;2022-01

5. A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention;Pharmacology Research & Perspectives;2021-05